Mastering Particle Size: Exploring Milling Techniques & Technologies Used for Pharmaceutical Micronization
Summary: This article provides an in-depth review of milling equipment, including jet, pin, hammer, conical, and cryogenic mills.
Pathways for Nasal Delivery
Nasal development is an attractive option but can be difficult, requiring expertise to overcome formulation challenges, and to navigate the complexities of drug/device combination products to optimize drug delivery.
Nasal Powder: A Stable, Rapid-Onset Strategy for Systemic Therapy
Summary: Originally published in Inhalation magazine, this article discusses how nasal powder formulations represent a significant stride in drug delivery innovation. With drug developers and approvers evolving to address the unique considerations of nasal drug delivery, nasal powders offer a robust and adaptable platform in the pharmaceutical landscape.
ARCUS®: A Commercialized Technology Enabling High-Dose, Highly Respirable Powders
Summary: In this article, Dr. Alan Watts, Director of Innovation & Partnerships for Orally Inhaled Products at Catalent, and Michael Tauber, Senior Director of Pharmaceutical Development at Acorda Therapeutics discuss the requirements and benefits of using spray-dried powders for inhalation, and how ARCUS can be used to successfully bring new inhaled therapies to market.
Your Perfect Partner for Dry Powder Inhalation
Summary: This article discusses how to successfully develop and manufacture spray-dried pulmonary and nasal powders and how a CDMO partner plays an integral role in the successful development and commercialization of inhalation products.
Nitrosamine Testing Services
Summary: Download this fact sheet to learn more about our experience and expertise with nitrosamines testing.